Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.
Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.
复制标题
DOI:
10.1021/jm800861c
复制
发表时间:
2009-05-28
影响因子:
7.3
通讯作者:
Gottesman MM
中科院分区:
文献类型:
--
作者:
Hall MD;Salam NK;Hellawell JL;Fales HM;Kensler CB;Ludwig JA;Szakács G;Hibbs DE;Gottesman MM
We have recently identified a new class of compounds that selectively kill cells that express P-glycoprotein (P-gp, MDR1), the ATPase efflux pump that confers multidrug resistance on cancer cells. Several isatin-β-thiosemicarbazones from our initial study have been validated, and a range of analogs synthesized and tested. A number demonstrated improved MDR1-selective activity over the lead, NSC73306 (1). Pharmacophores for cytotoxicity and MDR1-selectivity were generated to delineate the structural features required for activity. The MDR1-selective pharmacophore highlights the importance of aromatic/hydrophobic features at the N4 position of the thiosemicarbazone, and the reliance on the isatin moiety as key bioisosteric contributors. Additionally, a quantitative structure-activity relationship (QSAR) model that yielded a cross-validated correlation coefficient of 0.85 effectively predicts the cytotoxicty of untested thiosemicarbazones. Together, the models serve as effective approaches for predicting structures with MDR1-selective activity, and aid in directing the search for the mechanism of action of 1.
登录
查看更多内容
影响因子:
15
作者:
CARPINO, LA
通讯作者:
CARPINO, LA
DOI:
10.1073/pnas.70.1.164
发表时间:
1973-01-01
影响因子:
11.1
作者:
LEVINSON, W;FARAS, A;BISHOP, JM
通讯作者:
BISHOP, JM
影响因子:
3.5
作者:
Dixon, Steven L.;Smondyrev, Alexander M.;Friesner, Richard A.
通讯作者:
Friesner, Richard A.
影响因子:
3.3
作者:
DEAN, RT;NICHOLSON, P
通讯作者:
NICHOLSON, P
影响因子:
6.7
作者:
Karali, N
通讯作者:
Karali, N